All Stories

  1. Beyond Fumigatus : a molecular portrait of clinical Aspergillus diversity, pathogenicity, and antifungal resistance

    Article • Antimicrobial Agents and Chemotherapy, February 2026, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  2. Neutralizing GM-CSF autoantibodies impair neutrophil antifungal effector function in a patient with aspergillosis

    Article • Journal of Infection, September 2025, Elsevier

    Dr Seyedmojtaba Seyedmousavi

  3. Spectrum of clinically significant melanized fungi in NIH hospitalized patients and their antifungal susceptibility profiles

    Article • Medical Mycology, August 2025, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi

  4. Establishment of epidemiological cutoff values for Fonsecaea pedrosoi , the primary etiologic agent of chromoblastomycosis, and eight antifungal medications

    Article • Journal of Clinical Microbiology, May 2025, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  5. Clinical significance and antifungal susceptibility profile of 103 clinical isolates of Scedosporium species complex and Lomentospora prolificans obtained from NIH patients

    Article • Journal of Clinical Microbiology, April 2025, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  6. Characterization of COVID‐19‐Associated Candidemia Among Burn Patients

    Article • Journal of Clinical Laboratory Analysis, April 2025, Wiley

    Javad Javidnia, mahdi abastabar, Dr Seyedmojtaba Seyedmousavi

  7. Acanthamoeba Infection in a Hematopoietic Cell Transplant Recipient: Challenges in Diagnosis, Management, and Source Identification

    Article • Transplant Infectious Disease, December 2024, Wiley

    Dr Seyedmojtaba Seyedmousavi

  8. Asymptomatic colonization of stray dogs and domestic cats with Trichophyton mentagrophytes II in Northern Iran

    Article • Journal de Mycologie Médicale, September 2024, Elsevier

    Dr Seyedmojtaba Seyedmousavi

  9. Mucor germinans, a novel dimorphic species resembling Paracoccidioides in a clinical sample: questions on ecological strategy

    Article • mBio, August 2024, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  10. Development and preclinical validation of 2-deoxy 2-[ 18 F]fluorocellobiose as an Aspergillus -specific PET tracer

    Article • Science Translational Medicine, August 2024, American Association for the Advancement of Science

    Dr Seyedmojtaba Seyedmousavi

  11. Multi‐state evaluation of Candida infections in burn patients

    Article • Mycoses, August 2024, Wiley

    Javad Javidnia, mahdi abastabar, Dr Seyedmojtaba Seyedmousavi

  12. High Prevalence of Terbinafine Resistance Among Trichophyton mentagrophytes/T. interdigitale Species Complex, a Cross-Sectional Study from 2021 to 2022 in Northern Parts of Iran

    Article • Mycopathologia, June 2024, Springer Science + Business Media

    Javad Javidnia, Dr Seyedmojtaba Seyedmousavi

  13. Molecular Epidemiology and Antifungal Susceptibility Profile in Nakaseomyces glabrata Species Complex: A 5‐Year Countrywide Study

    Article • Journal of Clinical Laboratory Analysis, May 2024, Wiley

    Javad Javidnia, Dr. Hossein Zarrinfar, Dr Seyedmojtaba Seyedmousavi

  14. Reply to Kidd et al., “Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion”

    Article • Journal of Clinical Microbiology, April 2024, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  15. Tinea capitis due to Microsporum ferrugineum: A case of unusual laboratory finding on direct microscopic examination of infected hairs and skin lesions

    Article • Medical Mycology Case Reports, March 2024, Elsevier

    Dr Seyedmojtaba Seyedmousavi

  16. Multi-drug resistance Trichophyton indotineae in a stray dog

    Article • Research in Veterinary Science, January 2024, Elsevier

    Dr Seyedmojtaba Seyedmousavi

  17. 2758. Clinical Significance and Antifungal Susceptibility Profile of 103 Clinical Scedosporium Species Complex and Lomentospora prolificans Isolated from NIH Hospitalized Patients

    Article • Open Forum Infectious Diseases, November 2023, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi

  18. A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC

    Article • Journal of Clinical Microbiology, November 2023, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  19. Central nervous system Aspergillus quadrilineatus infection in a COVID‐19 patient, a case report and literature review

    Article • Journal of Clinical Laboratory Analysis, October 2023, Wiley

    Javad Javidnia, Dr Seyedmojtaba Seyedmousavi

  20. Successful Treatment of Paecilomyces variotii Pneumonia and Lupus Nephritis With Posaconazole-Cyclophosphamide Co-administration Without Drug Interaction–Induced Toxicity

    Article • Open Forum Infectious Diseases, August 2023, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi

  21. Treatment recommendations for non-HIV associated cryptococcal meningoencephalitis including management of post-infectious inflammatory response syndrome

    Article • Frontiers in Neurology, December 2022, Frontiers

    Dr Seyedmojtaba Seyedmousavi

  22. P148 Emerging and cryptic Aspergillus species isolated from hospitalized patients with underlying primary immunodeficiencies

    Article • Medical Mycology, September 2022, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi

  23. S10.5d Disseminated pulmonary infection due to Mortierella wolfii in a 6-year-old patient with X-linked CGD receiving MUD-HSCT

    Article • Medical Mycology, September 2022, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi

  24. P081 Azole-resistant Aspergillus fumigatus among NIH hospitalized patients with underlying primary immunodeficiencies

    Article • Medical Mycology, September 2022, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi

  25. Development of RFLP method for rapid differentiation of Aspergillus flavus and Aspergillus oryzae, two species with high importance in clinical and food microbiology

    Article • Journal de Mycologie Médicale, August 2022, Elsevier

    mahdi abastabar, Dr Seyedmojtaba Seyedmousavi

  26. An overview of COVID-19 related to fungal infections: what do we know after the first year of pandemic?

    Article • Brazilian Journal of Microbiology, March 2022, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  27. Control of Human and Animal Aspergillosis – a Health Approach

    Article • January 2022, Frontiers

    Dr Seyedmojtaba Seyedmousavi

  28. Differentiation of Aspergillus flavus from Aspergillus oryzae Targeting the cyp51A Gene

    Article • Pathogens, October 2021, MDPI AG

    mahdi abastabar, Dr Seyedmojtaba Seyedmousavi

  29. In Vivo Efficacy of Olorofim against Systemic Scedosporiosis and Lomentosporiosis

    Article • Antimicrobial Agents and Chemotherapy, September 2021, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  30. Genotyping and In Vitro Antifungal Susceptibility Profile of Neoscytalidium Species Isolates from Respiratory Tract

    Article • Mycopathologia, July 2021, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  31. Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC)

    Article • Journal of Clinical Microbiology, June 2021, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  32. Cutaneous hyalohyphomycosis due to Petriella setifera following traumatic inoculation in an immunocompetent host

    Article • Medical Mycology Case Reports, June 2021, Elsevier

    Dr Seyedmojtaba Seyedmousavi

  33. Antifungal Susceptibility Profiles of Olorofim (Formerly F901318) and Currently Available Systemic Antifungals against Mold and Yeast Phases of Talaromyces marneffei

    Article • Antimicrobial Agents and Chemotherapy, May 2021, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  34. Antifungal Drugs

    Article • April 2021, Wiley

    Dr Seyedmojtaba Seyedmousavi

  35. Recent Advances in Genome Editing Tools in Medical Mycology Research

    Article • Journal of Fungi, March 2021, MDPI AG

    Dr Seyedmojtaba Seyedmousavi

  36. Diagnosis of allergic bronchopulmonary aspergillosis in patients with persistent allergic asthma using three different diagnostic algorithms

    Article • Mycoses, December 2020, Wiley

    Dr Seyedmojtaba Seyedmousavi

  37. Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study

    Article • Injury Prevention, August 2020, BMJ

    Dr Yuan-Pang Wang, Prof.Dr. Adnan Kisa, Amrit Banstola, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Getinet Ayano, Professor Yousef Khader, Professor Andrew Toyin Olagunju, Dr Shariful Islam, Dr marek majdan, Dr Aidin Abedi, Prof Joel Msafiri Francis, Dr Fakher Rahim, Dr Ashish D Badiye, Professor Erkin Mirrakhimov, Prof Tommi Vasankari, Dr Vahid Rashedi, Professor Vijay Kumar Chattu, Dr Hoa Do, Mr Nauman Khalid, Dr Garumma TOLU FEYISSA, Mostafa Dianati, Dr Akshaya Srikanth Bhagavathula, berhe Gebremichael, Dr Farshad Pourmalek, Dr Bereket Duko , Professor Bruno Ramos Nascimento, Dr Seyedmojtaba Seyedmousavi

  38. Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017

    Article • Nature Reports Stem Cells, July 2020, Springer Science + Business Media

    Dr Garumma TOLU FEYISSA, Turki Alanzi, Dr Yuan-Pang Wang, Prof.Dr. Adnan Kisa, Professor Stefan Lorkowski, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Professor HESHAM M. AL-MEKHLAFI, Professor Yousef Khader, Professor Andrew Toyin Olagunju, Dr Bereket Duko , Prof Joel Msafiri Francis, Dr Md Nuruzzaman Khan, Dr Fakher Rahim, Mr. Anemaw A. Asrat, Dr Ashish D Badiye, Dr Nelsensius Klau Fauk, Dr. Bolajoko O. Olusanya, Professor Erkin Mirrakhimov, Mr. Alex Yeshaneh, Rajaa Al-Raddadi, Gebrekiros Gebremichael, Dr Vahid Rashedi, Professor ORISH EBERE ORSAKWE, Dr. Ahmed I. Hasaballah, Professor Vijay Kumar Chattu, Mr Zelalem Alamrew Anteneh, Mr Nauman Khalid, Prof Maha El Tantawi, Mostafa Dianati, Muthupandian Saravanan, Dr Mohammad Hassan Emamian, Dr Farshad Pourmalek, Baye Dagnew, Dr Shariful Islam, Dr Shankar M Bakkannavar, Dr Amin Mousavi Khaneghah, Professor Bruno Ramos Nascimento, Dr Seyedmojtaba Seyedmousavi

  39. Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017

    Article • Injury Prevention, April 2020, BMJ

    Dr. Asres Bedaso Tilahune, Mr Raimundas Lunevicius, Dr Garumma TOLU FEYISSA, Prof. Maciej Banach, Prof Tommi Vasankari, Professor Yousef Khader, Kathryn H. Jacobsen, Prof.Dr. Adnan Kisa, Amrit Banstola, Melkamu Merid Mengesha , Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Getinet Ayano, Professor Andrew Toyin Olagunju, Dr Shariful Islam, Dr marek majdan, Dr Aidin Abedi, Prof Joel Msafiri Francis, Dr Fakher Rahim, Dr Ashish D Badiye, Professor Erkin Mirrakhimov, Professor Ashraf Fawzy Nabhan, Dr Vahid Rashedi, Professor Vijay Kumar Chattu, Mr Nauman Khalid, Gebrekiros Gebremichael, Mostafa Dianati, berhe Gebremichael, Dr Mohammad Hassan Emamian, Dr Bereket Duko , Professor Bruno Ramos Nascimento, Dr Seyedmojtaba Seyedmousavi

  40. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017

    Article • Nature Reports Stem Cells, April 2020, Springer Science + Business Media

    Mr Zelalem Alamrew Anteneh, Baye Dagnew, Turki Alanzi, Dr Garumma TOLU FEYISSA, Dr Senthilkumar Balakrishnan, Prof. Maciej Banach, Prof Tommi Vasankari, Mr. Habtamu Kebebe Kasaye, Dr Yuan-Pang Wang, Professor Yousef Khader, Dr Shariful Islam, Prof.Dr. Adnan Kisa, Dr Amin Mousavi Khaneghah, Professor Stefan Lorkowski, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Professor HESHAM M. AL-MEKHLAFI, Professor Andrew Toyin Olagunju, Dr Bereket Duko , Professor Alina Rodriguez, Prof Joel Msafiri Francis, Dr Md Nuruzzaman Khan, Dr Fakher Rahim, Mr. Anemaw A. Asrat, Dr Ashish D Badiye, Dr Nelsensius Klau Fauk, Dr. Bolajoko O. Olusanya, Professor Erkin Mirrakhimov, Rajaa Al-Raddadi, Gebrekiros Gebremichael, Dr Vahid Rashedi, Mr Nejimu Biza Zepro, Professor ORISH EBERE ORSAKWE, Dr. Ahmed I. Hasaballah, Professor Vijay Kumar Chattu, PhD. Carla Sofia FARINHA, Mr Nauman Khalid, Prof Maha El Tantawi, Dr Manfred Mario Kokou Accrombessi, Mostafa Dianati, Muthupandian Saravanan, Dr Mohammad Hassan Emamian, Dr Farshad Pourmalek, Dr Shankar M Bakkannavar, Dr Ruth W Kimokoti, Professor Bruno Ramos Nascimento, Dr Seyedmojtaba Seyedmousavi

  41. Multicenter Cryptococcal Antigen Screening of HIV-Infected Patients in Iran

    Article • Current Microbiology, April 2020, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  42. Cryptococcus and cryptococcosis in Iran during 1969–2019: A systematic review and meta-analysis

    Article • Journal de Mycologie Médicale, April 2020, Elsevier

    Javad Javidnia, Dr Seyedmojtaba Seyedmousavi

  43. Annotated Genome Sequence of Aspergillus tanneri NIH1004

    Article • Microbiology Resource Announcements, January 2020, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  44. Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017

    Article • The Lancet Infectious Diseases, January 2020, Elsevier

    Prof Tommi Vasankari, Professor Yousef Khader, Prof.Dr. Adnan Kisa, Professor Andrew Toyin Olagunju, Dr Md Nuruzzaman Khan, Dr Fakher Rahim, Professor Erkin Mirrakhimov, Rajaa Al-Raddadi, Dr Garumma TOLU FEYISSA, Dr Ruth W Kimokoti, Dr Seyedmojtaba Seyedmousavi

  45. Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017

    Article • The Lancet Infectious Diseases, January 2020, Elsevier

    Prof Tommi Vasankari, Professor Yousef Khader, Prof.Dr. Adnan Kisa, Professor Andrew Toyin Olagunju, Dr Md Nuruzzaman Khan, Dr Fakher Rahim, Professor Erkin Mirrakhimov, Rajaa Al-Raddadi, Dr Garumma TOLU FEYISSA, Dr Ruth W Kimokoti, Dr Seyedmojtaba Seyedmousavi

  46. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

    Article • The Lancet Infectious Diseases, December 2019, Elsevier

    Dr Eric Dannaoui, Dr Seyedmojtaba Seyedmousavi

  47. Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complex

    Article • Journal of Medical Microbiology, November 2019, Society for General Microbiology

    mahdi abastabar, Dr Hamid Badali, Dr Seyedmojtaba Seyedmousavi

  48. Cryptococcus neoformans Recovered From Olive Trees (Olea europaea) in Turkey Reveal Allopatry With African and South American Lineages

    Article • Frontiers in Cellular and Infection Microbiology, November 2019, Frontiers

    Dr Seyedmojtaba Seyedmousavi

  49. Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources

    Article • Mycoses, November 2019, Wiley

    Dr. Hossein Zarrinfar, mahdi abastabar, Dr Seyedmojtaba Seyedmousavi

  50. Mapping 123 million neonatal, infant and child deaths between 2000 and 2017

    Article • Nature, October 2019, Springer Science + Business Media

    Amir Shamshirian, Dr Yuan-Pang Wang, Dr Vahid Rashedi, Professor Yousef Khader, ED Doris V. Ortega-Altamirano, Prof.Dr. Adnan Kisa, Professor Stefan Lorkowski, Professor HESHAM M. AL-MEKHLAFI, Professor Andrew Toyin Olagunju, Dr Shariful Islam, Prof Joel Msafiri Francis, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Professor Erkin Mirrakhimov, Gebrekiros Gebremichael, Dr Olayinka Stephen Ilesanmi, Dr solomon Olum, Prof Maha El Tantawi, Dr Garumma TOLU FEYISSA, Dr Mohammad Hassan Emamian, Dr Ruth W Kimokoti, Dr Seyedmojtaba Seyedmousavi

  51. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

    Article • JAMA Oncology, September 2019, American Medical Association (AMA)

    Amir Shamshirian, Dr Andre Luiz Sena Guimaraes, Dr Garumma TOLU FEYISSA, Mr Raimundas Lunevicius, Dr Senthilkumar Balakrishnan, Professor Yousef Khader, ED Doris V. Ortega-Altamirano, Prof.Dr. Adnan Kisa, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Professor Andrew Toyin Olagunju, Dr Shariful Islam, Dr Fakher Rahim, Mr. Alex Yeshaneh, Gebrekiros Gebremichael, Professor Ashraf Fawzy Nabhan, Professor Vijay Kumar Chattu, Dr. Mohammad Hossein Khosravi, Assistant professor kebadnew Mulatu Mihretie, Dr Mohammad Hassan Emamian, Dr Farshad Pourmalek, Mr Fitsum Weldegebreal Mlashu, Dr Seyedmojtaba Seyedmousavi

  52. Discrimination of Aspergillus flavus from Aspergillus oryzae by matrix‐assisted laser desorption/ionization time‐of‐flight (MALDI‐TOF) mass‐spectrometry

    Article • Mycoses, September 2019, Wiley

    Dr. Hossein Zarrinfar, mahdi abastabar, Dilara Ogunc, Dr Seyedmojtaba Seyedmousavi

  53. National trends in incidence, prevalence and disability-adjusted life years of invasive aspergillosis in Iran: a systematic review and meta-analysis

    Article • Expert Review of Respiratory Medicine, August 2019, Taylor & Francis

    Mr Mahmood moosazadeh, Dr Seyedmojtaba Seyedmousavi, Prof David W Denning, Mohammad T. Hedayati

  54. Cryptococcus neoformans recovered from olive trees ( Olea europaea ) in Turkey reveal allopatry with African and South American lineages

    Article • August 2019, openRxiv

    Dr Seyedmojtaba Seyedmousavi

  55. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017

    Article • The Lancet HIV, August 2019, Elsevier

    Daniel Asmelash , Kathryn H. Jacobsen, Professor Yousef Khader, Prof.Dr. Adnan Kisa, Professor Andrew Toyin Olagunju, Dr Bereket Duko , Dr Fakher Rahim, Mr. Anemaw A. Asrat, Gebrekiros Gebremichael, Professor Vijay Kumar Chattu, Dr Olayinka Stephen Ilesanmi, Dr solomon Olum, Melese Reta, Mr Nauman Khalid, Dr Garumma TOLU FEYISSA, Muthupandian Saravanan, Dr Seyedmojtaba Seyedmousavi, Dr Tesfaye Setegn Mengistu

  56. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017

    Article • The Lancet Oncology, July 2019, Elsevier

    Dr Mohammad Hassan Emamian, Amir Shamshirian, Professor Yousef Khader, Prof.Dr. Adnan Kisa, Professor Andrew Toyin Olagunju, Sok King Ong, Dr Seyedmojtaba Seyedmousavi

  57. Identification of clinical dermatophyte isolates obtained from Iran by matrix-assisted laser desorption/ionization time-offlight mass spectrometry

    Article • Current Medical Mycology, June 2019, Knowledge E

    mahdi abastabar, Dr Seyedmojtaba Seyedmousavi

  58. Department of Error

    Article • The Lancet, June 2019, Elsevier

    Prof.Dr. Adnan Kisa, Professor Stefan Lorkowski, Professor HESHAM M. AL-MEKHLAFI, Professor Yousef Khader, Professor Andrew Toyin Olagunju, PhD. Carla Sofia FARINHA, Dr Fakher Rahim, Mr. Alex Yeshaneh, Professor Ashraf Fawzy Nabhan, DR Lambert Tetteh Appiah, Professor Erkin Mirrakhimov, Mr Zegeye Abebe, Mr Nauman Khalid, Professor Vijay Kumar Chattu, Farhad Shokraneh, Dr Shariful Islam, Dr. Bolajoko O. Olusanya, Professor Bruno Ramos Nascimento, Dr Seyedmojtaba Seyedmousavi

  59. Efficacy of Olorofim (F901318) against Aspergillus fumigatus , A. nidulans , and A. tanneri in Murine Models of Profound Neutropenia and Chronic Granulomatous ...

    Article • Antimicrobial Agents and Chemotherapy, June 2019, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  60. Ochroconis globalis infecting Atlantic salmon ( Salmo salar ), with a review of Ochroconis species in cold‐blooded animals

    Article • Journal of Fish Diseases, April 2019, Wiley

    Dr Seyedmojtaba Seyedmousavi

  61. Antifungal Susceptibility Profile of Candida Albicans Isolated from Vulvovaginal Candidiasis in Xinjiang Province of China

    Article • Mycopathologia, April 2019, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  62. Fungal epidemiology in cystic fibrosis patients with a special focus on Scedosporium species complex

    Article • Microbial Pathogenesis, April 2019, Elsevier

    mahdi abastabar, Dr Seyedmojtaba Seyedmousavi

  63. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017

    Article • The Lancet Respiratory Medicine, January 2019, Elsevier

    Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Mr. Tara Ballav Adhikari, Professor Yousef Khader, Prof.Dr. Adnan Kisa, Professor Andrew Toyin Olagunju, Dr Md Nuruzzaman Khan, Rajaa Al-Raddadi, Dr Ruth W Kimokoti, Dr Seyedmojtaba Seyedmousavi

  64. Aspergillosis in Humans and Animals

    Article • January 2019, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  65. Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study

    Article • The Lancet Infectious Diseases, December 2018, Elsevier

    Kathryn H. Jacobsen, Ebrahim M. Yimer, Professor Yousef Khader, Professor Andrew Toyin Olagunju, Dr Olayinka Stephen Ilesanmi, Mr Zegeye Abebe, Prof. Sarman Singh, Mr Fitsum Weldegebreal Mlashu, Dr Seyedmojtaba Seyedmousavi, Dr Tesfaye Setegn Mengistu

  66. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Article • The Lancet, November 2018, Elsevier

    Kathryn H. Jacobsen, A/Prof Chris Lonsdale, Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr Shariful Islam, Farhad Shokraneh, Dr Gebre Teklemariam Demoz, Dr Andre Luiz Sena Guimaraes, Dr Yuan-Pang Wang, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Garumma TOLU FEYISSA, Dr Azmeraw Amare, Professor Amanda G Thrift, Mr Raimundas Lunevicius, Professor Yousef Khader, Mr. Aklilu Abrham, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Professor Stefan Lorkowski, Professor Andrew Toyin Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Mr. Alex Yeshaneh, Rajaa Al-Raddadi, Dr Olayinka Stephen Ilesanmi, Dr. Mohammad Hossein Khosravi, Mr Zegeye Abebe, Mr Nauman Khalid, Sok King Ong, Dr Manfred Mario Kokou Accrombessi, Dr. Mohammad Rifat Haider, Muthupandian Saravanan, Professor Vijay Kumar Chattu, Dr Ruth W Kimokoti, Mr Fitsum Weldegebreal Mlashu, Professor Bruno Ramos Nascimento, Dr Seyedmojtaba Seyedmousavi, Dr Tesfaye Setegn Mengistu

  67. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease ...

    Article • The Lancet, November 2018, Elsevier

    Kathryn H. Jacobsen, Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr Shariful Islam, Farhad Shokraneh, Dr Gebre Teklemariam Demoz, Dr Yuan-Pang Wang, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Mr. Aklilu Abrham, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Professor Stefan Lorkowski, Professor HESHAM M. AL-MEKHLAFI, Professor Andrew Toyin Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Professor Ashraf Fawzy Nabhan, DR Lambert Tetteh Appiah, Professor Vijay Kumar Chattu, Dr Olayinka Stephen Ilesanmi, Dr. Mohammad Hossein Khosravi, Mr Zegeye Abebe, Mr Nauman Khalid, Sok King Ong, Dr Manfred Mario Kokou Accrombessi, Dr Ruth W Kimokoti, Mr Fitsum Weldegebreal Mlashu, Professor Bruno Ramos Nascimento, Dr Seyedmojtaba Seyedmousavi

  68. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Article • The Lancet, November 2018, Elsevier

    Kathryn H. Jacobsen, Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr Shariful Islam, Farhad Shokraneh, Dr Gebre Teklemariam Demoz, Dr Yuan-Pang Wang, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Mr Raimundas Lunevicius, Professor Yousef Khader, Mr. Aklilu Abrham, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Professor Stefan Lorkowski, Professor HESHAM M. AL-MEKHLAFI, Professor Andrew Toyin Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Mr. Alex Yeshaneh, Rajaa Al-Raddadi, Professor Ashraf Fawzy Nabhan, Professor Vijay Kumar Chattu, Dr Olayinka Stephen Ilesanmi, Dr. Mohammad Hossein Khosravi, Mr Zegeye Abebe, Mr Nauman Khalid, Sok King Ong, Dr Manfred Mario Kokou Accrombessi, Dr Garumma TOLU FEYISSA, Dr. Mohammad Rifat Haider, Dr Ruth W Kimokoti, Mr Fitsum Weldegebreal Mlashu, Dr Seyedmojtaba Seyedmousavi, Dr Tesfaye Setegn Mengistu

  69. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Article • The Lancet, November 2018, Elsevier

    Kathryn H. Jacobsen, Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr Shariful Islam, Farhad Shokraneh, Dr Gebre Teklemariam Demoz, Dr Yuan-Pang Wang, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Garumma TOLU FEYISSA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Amrit Banstola, Professor Stefan Lorkowski, Professor HESHAM M. AL-MEKHLAFI, Professor Andrew Toyin Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Mr. Alex Yeshaneh, Rajaa Al-Raddadi, Prof Tommi Vasankari, Professor Ashraf Fawzy Nabhan, Professor Vijay Kumar Chattu, Dr Olayinka Stephen Ilesanmi, Dr. Mohammad Hossein Khosravi, Mr Zegeye Abebe, Mr Nauman Khalid, Sok King Ong, Dr Manfred Mario Kokou Accrombessi, Dr. Mohammad Rifat Haider, Dr Ruth W Kimokoti, Mr Fitsum Weldegebreal Mlashu, Professor Bruno Ramos Nascimento, Dr Seyedmojtaba Seyedmousavi, Dr Tesfaye Setegn Mengistu

  70. Measuring progress of the health-related Sustainable Development Goals for 195 countries

    Article • The Lancet, November 2018, Elsevier

    Kathryn H. Jacobsen, Mr. Tara Ballav Adhikari, ED Doris V. Ortega-Altamirano, Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr Shariful Islam, Farhad Shokraneh, Dr Gebre Teklemariam Demoz, Dr Andre Luiz Sena Guimaraes, Dr Yuan-Pang Wang, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Garumma TOLU FEYISSA, Dr Azmeraw Amare, Professor Amanda G Thrift, Professor Yousef Khader, Mr. Aklilu Abrham, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Amrit Banstola, Professor Stefan Lorkowski, Professor HESHAM M. AL-MEKHLAFI, Professor Andrew Toyin Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Mr. Alex Yeshaneh, Rajaa Al-Raddadi, Professor Ashraf Fawzy Nabhan, DR Lambert Tetteh Appiah, Professor Vijay Kumar Chattu, Dr Olayinka Stephen Ilesanmi, Dr. Mohammad Hossein Khosravi, Mr Zegeye Abebe, Mr Nauman Khalid, Sok King Ong, Dr Manfred Mario Kokou Accrombessi, Muthupandian Saravanan, Dr Ruth W Kimokoti, Mr Fitsum Weldegebreal Mlashu, Professor Bruno Ramos Nascimento, Dr Seyedmojtaba Seyedmousavi, Dr Tesfaye Setegn Mengistu

  71. Department of Error

    Article • The Lancet, November 2018, Elsevier

    Farhad Shokraneh, Dr Yuan-Pang Wang, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, A/Prof Chris Lonsdale, Dr Andre Luiz Sena Guimaraes, PhD. Carla Sofia FARINHA, Dr Garumma TOLU FEYISSA, Dr Azmeraw Amare, Professor Amanda G Thrift, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Professor Stefan Lorkowski, Professor Andrew Toyin Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Mr. Alex Yeshaneh, Rajaa Al-Raddadi, Dr Olayinka Stephen Ilesanmi, Dr. Mohammad Hossein Khosravi, Professor Erkin Mirrakhimov, Mr Zegeye Abebe, Mr Nauman Khalid, Muthupandian Saravanan, Dr Shariful Islam, Mr Fitsum Weldegebreal Mlashu, Professor Bruno Ramos Nascimento, Dr Seyedmojtaba Seyedmousavi

  72. Burden of fungal infections in Iran

    Article • The Journal of Infection in Developing Countries, October 2018, Journal of Infection in Developing Countries

    Dr Seyedmojtaba Seyedmousavi

  73. MGL_3741 gene contributes to pathogenicity of Malassezia globosa in pityriasis versicolor

    Article • Mycoses, September 2018, Wiley

    Dr Seyedmojtaba Seyedmousavi

  74. Estimated burden of serious human fungal diseases in Turkey

    Article • Mycoses, September 2018, Wiley

    Dr Seyedmojtaba Seyedmousavi

  75. Emerging Aspergillus Species Almost Exclusively Associated With Primary Immunodeficiencies

    Article • Open Forum Infectious Diseases, September 2018, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi

  76. In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent of invasive aspergillosis

    Article • Journal of Infection and Chemotherapy, September 2018, Elsevier

    Dr. Hossein Zarrinfar, mahdi abastabar, Dr Seyedmojtaba Seyedmousavi

  77. Corrigendum: Fungal infections in animals: a patchwork of different situations

    Article • Medical Mycology, May 2018, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi

  78. Genetic Diversity and Antifungal Susceptibility of Candida parapsilosis Sensu Stricto Isolated from Bloodstream Infections in Turkish Patients

    Article • Mycopathologia, May 2018, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  79. Genetic diversity and antifungal susceptibility of Candida albicans isolated from Iranian patients

    Article • Medical Mycology, March 2018, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi

  80. Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung

    Article • mBio, March 2018, ASM Journals

    Dr Seyedmojtaba Seyedmousavi, Dr Kyung (or June) Joo Kwon-Chung

  81. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis

    Article • Antimicrobial Agents and Chemotherapy, March 2018, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  82. Fungal infections in animals: a patchwork of different situations

    Article • Medical Mycology, March 2018, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi

  83. Predominance of non- fumigatus Aspergillus species among patients suspected to pulmonary aspergillosis in a tropical and subtropical region of the Middle East

    Article • Microbial Pathogenesis, March 2018, Elsevier

    Dr Seyedmojtaba Seyedmousavi, Dr. Hossein Zarrinfar

  84. Overview of selected virulence attributes in Aspergillus fumigatus , Candida albicans , Cryptococcus neoformans , Trichophyton rubrum , and Exophiala dermatitidis

    Article • Fungal Genetics and Biology, February 2018, Elsevier

    Dr Seyedmojtaba Seyedmousavi

  85. Biofilm Formation and Resistance to Fungicides in Clinically Relevant Members of the Fungal Genus Fusarium

    Article • Journal of Fungi, January 2018, MDPI AG

    Dr Seyedmojtaba Seyedmousavi

  86. Aspergillus fumigatus alkaline protease 1 (Alp1/ Asp f13 ) in the airways correlates with asthma severity

    Article • Journal of Allergy and Clinical Immunology, January 2018, Elsevier

    Dr Seyedmojtaba Seyedmousavi

  87. Antifungal Use in Veterinary Practice and Emergence of Resistance

    Article • January 2018, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  88. Cryptococcosis: Emergence of Cryptococcus gattii in Animals and Zoonotic Potential

    Article • January 2018, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  89. Emerging and Epizootic Fungal Infections in Animals

    Article • January 2018, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  90. Defective calcineurin/NFAT signaling in myeloid cells and susceptibility to aspergillosis in post-transplant patients

    Article • Virulence, November 2017, Taylor & Francis

    Dr Seyedmojtaba Seyedmousavi

  91. Absent in vitro interaction between chloroquine and antifungals against Aspergillus fumigatus

    Article • Clinical Microbiology and Infection, September 2017, Elsevier

    Dr Seyedmojtaba Seyedmousavi

  92. Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis

    Article • Journal of Medical Microbiology, July 2017, Society for General Microbiology

    Dr Seyedmojtaba Seyedmousavi, Dr. Hossein Zarrinfar

  93. Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole

    Article • Medical Mycology Case Reports, June 2017, Elsevier

    Dr Seyedmojtaba Seyedmousavi

  94. In Vivo Efficacy of Liposomal Amphotericin B against Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates in Two Different Immunosuppression Models of Invasive Aspergillosis

    Article • Antimicrobial Agents and Chemotherapy, April 2017, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  95. Genetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates

    Article • Antimicrobial Agents and Chemotherapy, March 2017, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  96. Azole Resistance in Aspergillus fumigatus: Mechanisms, Route of Resistance Selection, and Clinical Implications

    Article • January 2017, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  97. In Vitro Antifungal Susceptibility Profiles of 12 Antifungal Drugs against 55 Trichophyton schoenleinii Isolates from Tinea Capitis Favosa Patients in Iran, Turkey, and China

    Article • Antimicrobial Agents and Chemotherapy, December 2016, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  98. Topical and systemic antifungals in dermatology practice

    Article • Expert Review of Clinical Pharmacology, December 2016, Taylor & Francis

    Dr Seyedmojtaba Seyedmousavi

  99. Systemic Antifungal Agents: Current Status and Projected Future Developments

    Article • November 2016, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  100. Aspergillus flavus Keratitis: Experience of a Tertiary Eye Clinic in Turkey

    Article • Mycopathologia, November 2016, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  101. Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis

    Article • Antimicrobial Agents and Chemotherapy, November 2016, ASM Journals

    Dr Seyedmojtaba Seyedmousavi, Dr Jacques F Meis

  102. Discrimination of Aspergillosis, Mucormycosis, Fusariosis, and Scedosporiosis in Formalin-Fixed Paraffin-Embedded Tissue Specimens by Use of Multiple Real-Time Quantitative PCR Assays

    Article • Journal of Clinical Microbiology, September 2016, ASM Journals

    Dr Seyedmojtaba Seyedmousavi, mahdi abastabar

  103. Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections

    Article • Mycopathologia, May 2016, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  104. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India

    Article • Mycopathologia, May 2016, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  105. Conventional Morphology Versus PCR Sequencing, rep-PCR, and MALDI-TOF-MS for Identification of ClinicalAspergillusIsolates Collected Over a 2-Year Period in a University Hospital at Kayseri, Turkey

    Article • Journal of Clinical Laboratory Analysis, March 2016, Wiley

    Dr Altay Atalay, Dr Seyedmojtaba Seyedmousavi

  106. Combination of Amphotericin B and Flucytosine against Neurotropic Species of Melanized Fungi Causing Primary Cerebral Phaeohyphomycosis

    Article • Antimicrobial Agents and Chemotherapy, February 2016, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  107. A 9-Month-Old Girl from Iran with Extensive Erythematous Plaques Due to Trichophyton simii, a Zoophilic Dermatophyte

    Article • Mycopathologia, January 2016, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  108. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses

    Article • Mycopathologia, November 2015, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  109. Infrequent Production of Xanthomegnin by Fungal Strains Recovered from Patients with Ocular Mycoses

    Article • Mycopathologia, November 2015, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  110. Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection

    Article • Antimicrobial Agents and Chemotherapy, November 2015, ASM Journals

    Professor Johan w mouton, Dr Seyedmojtaba Seyedmousavi

  111. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014

    Article • Antimicrobial Agents and Chemotherapy, November 2015, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  112. Dermatophytosis due to Microsporum incurvatum: Notification and Identification of a Neglected Pathogenic Species

    Article • Mycopathologia, September 2015, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi, KOICHI MAKIMURA, mahdi abastabar

  113. ATR-FTIR Spectroscopy Highlights the Problem of Distinguishing Between Exophiala dermatitidis and E. phaeomuriformis Using MALDI-TOF MS

    Article • Microbial Ecology, September 2015, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi, Dilara Ogunc

  114. Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran

    Article • Mycopathologia, September 2015, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi, Dr Hamid Badali

  115. Clinical and Laboratory Features of Six Cases of Candida and Dermatophyte Folliculitis and a Review of Published Studies

    Article • Mycopathologia, September 2015, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  116. Aspergillusand aspergilloses in wild and domestic animals: a global health concern with parallels to human disease

    Article • Medical Mycology, August 2015, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi

  117. Epidemiological changes in tinea capitis over the sixty years of economic growth in China

    Article • Medical Mycology, August 2015, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi, Dr Giorgio Ciprandi

  118. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus

    Article • Drug Resistance Updates, July 2015, Elsevier

    Dr Seyedmojtaba Seyedmousavi, Dr Jacques F Meis

  119. Emergence of fusarioses in a university hospital in Turkey during a 20-year period

    Article • European Journal of Clinical Microbiology & Infectious Diseases, May 2015, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  120. Neglected fungal zoonoses: hidden threats to man and animals

    Article • Clinical Microbiology and Infection, May 2015, Elsevier

    Dr Seyedmojtaba Seyedmousavi

  121. Comparison of theIn VitroActivities of Newer Triazoles and Established Antifungal Agents against Trichophyton rubrum

    Article • Antimicrobial Agents and Chemotherapy, April 2015, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  122. Plasma and Epithelial Lining Fluid Pharmacokinetics of Ceftolozane and Tazobactam Alone and in Combination in Mice

    Article • Antimicrobial Agents and Chemotherapy, March 2015, ASM Journals

    Professor Johan w mouton, Dr Seyedmojtaba Seyedmousavi

  123. Pharmacodynamics of Isavuconazole in an Aspergillus fumigatus Mouse Infection Model

    Article • Antimicrobial Agents and Chemotherapy, March 2015, ASM Journals

    Professor Johan w mouton, Dr Seyedmojtaba Seyedmousavi, Dr Jacques F Meis

  124. Pharmacokinetics and Penetration of Ceftazidime and Avibactam into Epithelial Lining Fluid in Thigh- and Lung-Infected Mice

    Article • Antimicrobial Agents and Chemotherapy, February 2015, ASM Journals

    Professor Johan w mouton, Dr Seyedmojtaba Seyedmousavi

  125. Azole Resistance in Aspergillus fumigatus: Mechanisms, Route of Resistance Selection, and Clinical Implications

    Article • January 2015, Springer Science + Business Media

    Dr Seyedmojtaba Seyedmousavi

  126. Candida ve Kandidoz: Epidemiyoloji, Tanı, Tedavi, Antifungal İlaç Direnci ve Konağın Genetik Yatkınlığında Güncel Durum

    Article • Türk Mikrobiyoloji Cemiyeti Dergisi, January 2015, Logos Medical Publication (Logos Yayincilik Tic. A.S.)

    Dr Seyedmojtaba Seyedmousavi

  127. Posaconazole Prophylaxis in Experimental Azole-Resistant Invasive Pulmonary Aspergillosis

    Article • Antimicrobial Agents and Chemotherapy, December 2014, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  128. In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients

    Article • Journal of Antimicrobial Chemotherapy, December 2014, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi

  129. Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases

    Article • Expert Review of Anti-infective Therapy, December 2014, Taylor & Francis

    Dr Seyedmojtaba Seyedmousavi

  130. The role of azoles in the management of azole-resistant aspergillosis: From the bench to the bedside

    Article • Drug Resistance Updates, July 2014, Elsevier

    Dr Seyedmojtaba Seyedmousavi

  131. Black Yeasts and Their Filamentous Relatives: Principles of Pathogenesis and Host Defense

    Article • Clinical Microbiology Reviews, June 2014, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  132. Effects of Low-Level Laser Irradiation on the Pathogenicity ofCandida albicans:In Vitro and in VivoStudy

    Article • Photomedicine and Laser Surgery, June 2014, Mary Ann Liebert Inc

    Dr Seyedmojtaba Seyedmousavi

  133. Antifungal Susceptibility Patterns of Opportunistic Fungi in the Genera Verruconis and Ochroconis

    Article • Antimicrobial Agents and Chemotherapy, March 2014, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  134. Intrapulmonary Posaconazole Penetration at the Infection Site in an Immunosuppressed Murine Model of Invasive Pulmonary Aspergillosis Receiving Oral Prophylactic Regimens

    Article • Antimicrobial Agents and Chemotherapy, February 2014, ASM Journals

    Professor Johan w mouton, Dr Seyedmojtaba Seyedmousavi

  135. Continuous Infusion of Amphotericin B Deoxycholate for the Treatment of Life-ThreateningCandidaInfections

    Article • American Review of Respiratory Disease, October 2013, American Thoracic Society

    Dr Seyedmojtaba Seyedmousavi

  136. Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis

    Article • Expert Review of Anti-infective Therapy, September 2013, Taylor & Francis

    Dr Seyedmojtaba Seyedmousavi

  137. Azole-ResistantAspergillus fumigatus, Iran

    Article • Emerging Infectious Diseases, May 2013, Centers for Disease Control and Prevention (CDC)

    Dr Seyedmojtaba Seyedmousavi

  138. Pharmacodynamics and Dose-Response Relationships of Liposomal Amphotericin B against Different Azole-Resistant Aspergillus fumigatus Isolates in a Murine Model of Disseminated Aspergillosis

    Article • Antimicrobial Agents and Chemotherapy, February 2013, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  139. Phaeohyphomycoses, Emerging Opportunistic Diseases in Animals

    Article • Clinical Microbiology Reviews, January 2013, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  140. In Vitro Interaction of Voriconazole and Anidulafungin against Triazole-Resistant Aspergillus fumigatus

    Article • Antimicrobial Agents and Chemotherapy, November 2012, ASM Journals

    Dr Seyedmojtaba Seyedmousavi

  141. Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis

    Article • Journal of Antimicrobial Chemotherapy, November 2012, Oxford University Press (OUP)

    Dr Seyedmojtaba Seyedmousavi

  142. Pharmacodynamics of Anidulafungin against Clinical Aspergillus fumigatus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis

    Article • Antimicrobial Agents and Chemotherapy, October 2012, ASM Journals

    Professor Johan w mouton, Dr Seyedmojtaba Seyedmousavi

  143. Multiple subcutaneous cysts due toExophiala spiniferain an immunocompetent patient

    Article • Medical Mycology, February 2012, Oxford University Press (OUP)

    Dr Jacques F Meis, Dr Seyedmojtaba Seyedmousavi, Dr Hamid Badali

  144. Waterborne Exophiala species causing disease in cold-blooded animals

    Article • Persoonia - Molecular Phylogeny and Evolution of Fungi, December 2011, Naturalis Biodiversity Center

    Dr Seyedmojtaba Seyedmousavi, Dr Hamid Badali

  145. Assessment of efficacy of antifungals in experimental models of invasive aspergillosis in an era of emerging resistance: the value of real-time quantitative PCR

    Article • Current Opinion in Pharmacology, October 2011, Elsevier

    Dr Seyedmojtaba Seyedmousavi

  146. Exophiala sideris, a novel black yeast isolated from environments polluted with toxic alkyl benzenes and arsenic

    Article • Fungal Biology, October 2011, Elsevier

    Dr Seyedmojtaba Seyedmousavi, Dr Hamid Badali